SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications

Xue-Ting Zheng, Hui-Yi Xie, Xiu-Heng Wang, Yue Zhao, Jia-Yan Yang, Yun-Xi Liu, Xian-Liang Yuan, Hui-Fang Tang, Zhi-Sheng Jiang, Heng-Jing Hu · 2026

Read SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications by Xue-Ting Zheng, Hui-Yi Xie, Xiu-Heng Wang, Yue Zhao, Jia-Yan Yang, Yun-Xi Liu, Xian-Liang Yuan, Hui-Fang Tang, Zhi-Sheng Jiang, Heng-Jing Hu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13627522.txt.

Description

Xue-Ting Zheng leads a ten-author review of SGLT2 inhibitors, diabetes drugs that have outgrown their first job. The target protein reclaims most filtered sugar in the kidney's early tubule, and blocking it spills sugar into urine, restores a feedback loop that guards the filter, and reshapes fluid balance. The review connects those kidney and circulation effects to body-wide shifts: a fasting-like signal, more red blood cell production, changed uric acid handling, and calmer cell stress, oxidation, and inflammation.

That web of actions explains the wins across three diseases it now treats: type 2 diabetes, long-running kidney damage, and heart failure. It also supports newer uses after heart attacks and in rhythm and liver disorders. The authors treat one fashionable mechanism, vessel lining cells turning to scar tissue, as a single thread rather than the whole cloth. Unresolved questions close the map.

Catalog record

CREATORXue-Ting Zheng, Hui-Yi Xie, Xiu-Heng Wang, Yue Zhao, Jia-Yan Yang, Yun-Xi Liu, Xian-Liang Yuan, Hui-Fang Tang, Zhi-Sheng Jiang, Heng-Jing Hu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE106 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13627522

Browse the full library · About the Tower of Babel